What’s keeping PrEP under wraps
PrEP, or pre-exposure prophylaxis, is a safe and effective medication that can prevent at-risk patients from contracting HIV, yet the treatment is not widely known by physicians or the patient base that could benefit most from it. Learn what HIV experts say about the treatment and the obstacles to integrating it into primary care practice.
Getting the word out
PrEP reaches a small proportion of the Americans who could benefit from it, experts said at an education session by the AMA LGBT Advisory Committee during the 2016 AMA Annual Meeting.
“What’s really interesting about it is a lot of people haven’t heard ab...
Source: AMA Wire - July 19, 2016 Category: Journals (General) Authors: Troy Parks Source Type: news
Bacterial Vaginosis Raises HIV Risk, Lowers Tenofovir Level Bacterial Vaginosis Raises HIV Risk, Lowers Tenofovir Level
Most new and existing HIV infections occur in Africa, and young women in particular have very high rates of infection; new research shows the treatment of bacterial vaginosis can reduce this risk. < br / > < i > Medscape Medical News < /i > (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 19, 2016 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news
Bacterial Vaginosis Raises HIV Risk, Lowers Tenofovir LevelBacterial Vaginosis Raises HIV Risk, Lowers Tenofovir Level
Most new and existing HIV infections occur in Africa, and young women in particular have very high rates of infection; new research shows the treatment of bacterial vaginosis can reduce this risk. Medscape Medical News (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 19, 2016 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news
ViiV reports ARIA Phase IIIb trial shows superior efficacy for Triumeq to treat HIV
ViiV Healthcare reported that phase IIIb of the ARIA study showed superior efficacy for Triumeq (dolutegravir / abacavir / lamivudine) compared with atazanavir boosted with ritonavir (ATV/r), along with tenofovir disoproxil fumarate / emtricitabine (… (Source: Drug Development Technology)
Source: Drug Development Technology - July 18, 2016 Category: Pharmaceuticals Source Type: news
Anti-HIV Pill Could Cut Infections in Gay, Bi Men by a ThirdAnti-HIV Pill Could Cut Infections in Gay, Bi Men by a Third
The rate of new HIV infections among gay and bisexual men could drop by up to a third over the next decade if enough eligible men use pre-exposure prophylaxis (PrEP) with Truvada (emtricitabine/tenofovir disoproxil fumarate), researchers estimate. Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 18, 2016 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news
Anti-HIV Pill Could Cut Infections in Gay, Bi Men by a Third Anti-HIV Pill Could Cut Infections in Gay, Bi Men by a Third
The rate of new HIV infections among gay and bisexual men could drop by up to a third over the next decade if enough eligible men use pre-exposure prophylaxis (PrEP) with Truvada (emtricitabine/tenofovir disoproxil fumarate), researchers estimate. < br / > < i > Reuters Health Information < /i > (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 18, 2016 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news
Long-term Safety of Nucleotide Analogues in HBV Infection Long-term Safety of Nucleotide Analogues in HBV Infection
What ' s the current data on long-term safety of entecavir and tenofovir disoproxil fumarate in the treatment of chronic HBV infection? < br / > < i > Alimentary Pharmacology & Therapeutics < /i > (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 15, 2016 Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news
Long-term Safety of Nucleotide Analogues in HBV InfectionLong-term Safety of Nucleotide Analogues in HBV Infection
What's the current data on long-term safety of entecavir and tenofovir disoproxil fumarate in the treatment of chronic HBV infection? Alimentary Pharmacology & Therapeutics (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - July 15, 2016 Category: Intensive Care Tags: Gastroenterology Journal Article Source Type: news
TDF reduces vertical HBV transmission
The mother-to-child transmission of hepatitis B virus is reduced with tenofovir disoproxil fumarate treatment during the third trimester in pregnant chronic HBV patients with a high viral load, show the findings of a trial conducted in China. (Source: MedWire News)
Source: MedWire News - July 4, 2016 Category: Consumer Health News Tags: HBV Source Type: news
Bone Mineral Density in Tenofovir-Exposed HIV PatientsBone Mineral Density in Tenofovir-Exposed HIV Patients
What causes bone mineral density decline in HIV patients on tenofovir? AIDS (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - June 22, 2016 Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news
ContraVir begins dosing in Phase lla trial of CMX157 comparing Viread to treat HBV
US-based biopharmaceutical company ContraVir Pharmaceuticals has initiated dosing patients in its head-to-head Phase lla trial comparing its CMX157 to tenofovir DF (TDF), marketed by Gilead Sciences as Viread to treat chronic hepatitis B (HBV). (Source: Drug Development Technology)
Source: Drug Development Technology - June 21, 2016 Category: Pharmaceuticals Source Type: news
New Tenofovir Easy on the Kidneys (CME/CE)
(MedPage Today) -- Little damage with drug designed to prevent renal problems in HIV patients (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - June 21, 2016 Category: Infectious Diseases Source Type: news
11 new AMA policies patients should know
At the heart of all policymaking of the AMA is the mission to promote the betterment of public health. Physicians at the 2016 AMA Annual Meeting adopted a variety of policies that will help improve consumer safety and reduce harm—they range from preventing drug overdose to delaying school start times and supporting paid sick leave.
1. Medication disposal programs could help prevent overdose, improve health
An unprecedented drug overdose epidemic in the United State could be addressed in part by stronger medication return programs that treat unused medications as hazardous waste. The AMA called for support of medicati...
Source: AMA Wire - June 15, 2016 Category: Journals (General) Authors: Amy Farouk Source Type: news
New AMA policies patients should know
At the heart of all policymaking of the AMA is the mission to promote the betterment of public health. Physicians at the 2016 AMA Annual Meeting adopted a variety of policies that will help improve consumer safety and reduce harm.
Dangers of detergent packets
Recognizing that concentrated detergent packets can compromise children’s health and safety, the AMA today adopted policy calling for the redesign of detergent product packages to make them less attractive to children to help prevent accidental exposure or ingestion.
According to a study published in the Journal of the American Academy of Pediatrics, between 2...
Source: AMA Wire - June 14, 2016 Category: Journals (General) Authors: Amy Farouk Source Type: news
Topical application of antiretroviral drug combination prevents transmission of (S)HIV
For the first time, researchers show that two powerful antiretroviral drugs can provide complete protection against HIV when delivered topically by a sustained release intravaginal ring (IVR) device. The combination of tenofovir disoproxil fumarate and emtricitabine delivered at independently controlled rates via the pod-IVR was successful at preventing SHIV162p3 infection for over four months. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 13, 2016 Category: Science Source Type: news
